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The miR-96, miR-182 and miR-183 microRNA (miRNA) family is essential for differentiation and function of the
vertebrate inner ear. Recently, point mutations within the seed region of miR-96 were reported in two Spanish
families with autosomal dominant non-syndromic sensorineural hearing loss (NSHL) and in a mouse model of
NSHL. We screened 882 NSHL patients and 836 normal-hearing Italian controls and identiﬁed one putative
novel mutation within the miR-96 gene in a family with autosomal dominant NSHL. Although located outside
the mature miR-96 sequence, the detected variant replaces a highly conserved nucleotide within the compan-
ion miR-96∗, and is predicted to reduce the stability of the pre-miRNA hairpin. To evaluate the effect of the
detected mutation on miR-96/mir-96∗ biogenesis, we investigated the maturation of miR-96 by transient
expression in mammalian cells, followed by real-time reverse-transcription polymerase chain reaction (PCR).
We found that both miR-96 and miR-96∗ levels were signiﬁcantly reduced in the mutant, whereas the precursor
levels were unaffected. Moreover, miR-96 and miR-96∗ expression levels could be restored by a compensatory
mutation that reconstitutes the secondary structure of the pre-miR-96 hairpin, demonstrating that the mutation
hinders precursor processing, probably interfering with Dicer cleavage. Finally, even though the mature miR-96
sequence is not altered, we demonstrated that the identiﬁed mutation signiﬁcantly impacts on miR-96 regula-
tion of selected targets. In conclusion, we provide further evidence of the involvement of miR-96 mutations in
human deafness and demonstrate that a quantitative defect of this miRNA may contribute to NSHL.
INTRODUCTION
MicroRNAs (miRNAs) are  21-nucleotide (nt)-long, single-
stranded noncoding RNAs that mainly function as post-
transcriptional regulators of gene expression. Once assembled
into an RNA-induced silencing complex, each miRNA might
inhibit the expression of hundreds of target messenger RNAs
(mRNAs), by inducing translational repression and/or
mRNA degradation (1). Animal miRNAs recognize partially
complementary binding sites, which are generally located in
the 3′ untranslated region (3′UTR) of target mRNAs. In par-
ticular, complementarity to the miRNA seed region,
corresponding to nts 2–8 at the 5′ of the mature miRNA, is
a major determinant in target recognition and is sufﬁcient to
trigger silencing (2).
MiRNAs are initially transcribed from endogenous genes as
long primary transcripts (pri-miRNAs), which contain
extended hairpin structures. The pri-miRNAs are then pro-
cessed by the Microprocessor complex into a hairpin precursor
(pre-miRNA), which is exported to the cytoplasm and cleaved
by the RNaseIII Dicer to generate a mature miRNA duplex
(3). Usually, one strand of the duplex is preferentially selected
for entry into the silencing complex to regulate gene expres-
sion, whereas the other strand, known as the passenger
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However, recent evidence demonstrated that miRNA∗ species
are often present at physiologically relevant levels, can associ-
ate with the silencing protein Argonaute and can inhibit target
mRNAs in both cultured cells and transgenic animals (4–8).
The miR-183 family is composed of three miRNAs
(miR-183, miR-96 and miR-182), which are coordinately
expressed from a single genetic locus in vertebrates. Homolo-
gous miRNAs (miR-228 and mir-263b) are also present in
invertebrates (9). Importantly, this highly conserved family
of miRNAs shows expression in ciliated neurosensory
organs across phyla and has recently been demonstrated to
contribute speciﬁcally to the differentiation and function of
the mechanosensory hair cells in the vertebrate inner ear
(10,11). For instance, in zebraﬁsh, the miR-183 family is pre-
dominantly expressed in the hair cells of the inner ear and of
the lateral line, as well as in the olfactory and retinal sensory
cells (12,13). Overexpression of miR-96 or miR-182, but not
of miR-183, was shown to induce duplicated otocysts,
ectopic or expanded sensory patches, and extra hair cells.
Conversely, knockdown of each of the three miRNAs led to
a reduction in the number of hair cells in the inner ear and
caused defects in semicircular canals, as well as the presence
of abnormal neuromasts in the lateral line (11).
In the human genome, the miR-183 family is clustered in a
4.5 kb region on chromosome 7q32, within a locus that has
been linked to autosomal dominant non-syndromic hearing
loss (NSHL) (DFNA50, OMIM #613074). In 2009, two muta-
tions in the seed region of miR-96 were detected in two
Spanish families affected by autosomal dominant progressive
NSHL. Both mutations (+13G.A and +14C.A) affect nts
that are fully conserved among vertebrates (from ﬁsh to
humans) and segregated with hearing loss in the affected fam-
ilies. The impact of these mutations on miR-96 processing
and target recognition was analyzed in HeLa and NIH-3T3
cells, showing that both mutations result in reduced levels of
mature miRNA and hinder its gene-silencing capacity (14).
Further evidence on the signiﬁcance of miR-96 expression
and function in the pathogenesis of hearing loss has been pro-
vided by genetic studies in the mouse, where a single nt substi-
tutionintheseedregionofthehomologofmiR-96wasshownto
cause progressive hearing loss and hair cell defects in a murine
model of sensorineural deafness, called diminuendo (15,16).
The work of Mencı ´a et al.( 14) represented the ﬁrst evidence
that point mutations in a miRNA can be responsible for a Men-
deliantrait.However,uptonow,themutationalscreeningofthe
miR-183familyhasbeenperformedonlyintheoriginalstudy—
including 567 Spanish families with inherited hearing loss
(14)—and in a single replication study on 150 American fam-
ilies with autosomal dominant NSHL, where no mutations
werefound(17).Therefore,apositivereplicationoftheﬁndings
by Mencı ´a et al. is still lacking.
In this study, we have identiﬁed a novel NSHL-causing
mutation within the MIR96 gene by screening a large case–
control Italian population. At variance with previously
reported mutations, this variation does not affect the miR-96
seed region, but alters the companion miR-96∗ sequence.
Through a series of functional studies, we have demonstrated
that this variant substantially impairs the production of mature
miR-96 by altering the pre-miRNA secondary structure, and
indirectly impacts on the normal regulation of miR-96
targets. Our results suggest that a quantitative defect of
miR-96 can be sufﬁcient to cause deafness. However, as we
have shown that the novel mutation also reduces the expres-
sion levels of miR-96∗ and potentially alters the recognition
of its targets, a contribution of this miRNA species to NSHL
pathogenesis cannot be ruled out.
RESULTS
A novel NSHL-causing mutation within the MIR96 gene
A cohort composed of 882 genetically undiagnosed Italian
NSHL patients, including sporadic and familial cases, and 836
normal-hearing Italian controls was screened for mutations in
miR-96,miR-182andmiR-183genes.Astrategybasedonapre-
screeningbyhigh-resolutionmelting(HRM) followedbydirect
sequencing was chosen. Neither of the two previously reported
miR-96 mutations was found, suggesting that they might repre-
sent private mutations. Instead, ﬁve heterozygous nt variations
were identiﬁed in NSHL cases (Supplementary Material,
Table S1): two of them, miR-96(+42C.T) and miR-182
(+106G.A),werepreviouslyreportedassinglentpolymorph-
isms (SNPs rs73159662 and rs76481776, respectively), and
were found also in controls. Two novel MIR183 variants,
miR-183(+3G.T) and miR-183(-27C.T), were detected,
each in one proband: both were located outside the mature
miRNA sequence at non-conserved nt residues, were absent in
normal-hearing controls, but did not segregate with hearing
loss in the corresponding families (the variants were absent in
at least one affected relative in the corresponding family). The
last variant identiﬁed, miR-96(+57T.C)
(NR_029512.1:c.57T.C; NT_007933.15:g.67447397A.G)
is located in the stem region of the pre-miRNA and replaces a
residue that is fully conserved throughout vertebrate evolution,
fromﬁshtoprimates(Fig.1A).Thisvariationaffectsthemature
miR-96∗, which is processed from the complementary strand of
the miR-96 precursor. In particular, the change occurs at pos-
ition +6, within the miR-96∗ seed region (Fig. 1A). The
miR-96∗ has been experimentally detected in humans, mouse,
platypus and zebraﬁsh (mirBase, http://www.mirbase.org/)
(18), suggesting that also the miRNA∗ species has been main-
tained throughout vertebrate evolution, although its sequence
is only partially conserved. However, very little is known
about miR-96∗ expression and function.
The miR-96(+57T.C) mutation was found in the hetero-
zygous state in a patient with a family history of autosomal
dominant progressive NSHL (with the age of onset ranging
from  25 to 40) and was absent in all 839 normal-hearing
controls. The proband is a profoundly deaf 56-year-old
woman with an affected brother, two normal hearing sisters
and three normal-hearing children (Fig. 1B and C). The pro-
band’s mother and grandmother were also profoundly deaf,
but with a various degree of hearing loss (the grandmother
being slightly more severe; Supplementary Material,
Fig. S1). The proband shows non-syndromic, bilateral, sen-
sorineural deafness that onset as a mild hearing impairment
at  25 years and slowly progressed ﬁrst to a severe form at
the age of 45 and then to a profound form in the sixth
decade (Fig. 1D). She presents a down-sloping audiometric
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Neither the proband nor any affected individuals of her
family referred visual or olfactory problems; however,
episodes of vertigo were reported in the proband (III-2), her
mother (II-2) and her brother (III-3). The miR-96(+57T.C)
variant segregates with the phenotype within the family,
being present in all affected individuals and absent in the
normal hearing individuals III-4 and IV-4. However, the vari-
ation is also present in the three normal-hearing proband’s
children (Fig. 1C and Supplementary Material, Fig. S1): this
may be due either to the age-relatedness of hearing loss in
the family (all non-penetrants are below the average age of
onset of the disease among affected relatives) or to incomplete
penetrance.
The 157T>C mutation impairs pre-miRNA processing
into mature miR-96 and miR-96∗
AsthemiR-96(+57T.C)variationislocatedinthestemregion
of the miRNA precursor, we used the mfold program (19)t o
examine how the newly identiﬁed nt variation could alter the
predicted RNA secondary structure of pre-miR-96. The
miR-96(+57T.C) substitution introduces a base-pairing mis-
match,decreasingthefreeenergyvalueandcreatinganenlarged
RNA bulge in the pre-miR-96 stem, close to the Dicer cleavage
site(Fig.2A).Inthisframe,wedecidedtoexaminetheimpactof
the novel variant on both miR-96 and miR-96∗ expression and
maturation. To this aim, expression vectors (psiUX) containing
genomic DNA fragments spanning both miR-183 and miR-96
Figure 1. The novel pre-miR-96(+57T.C) mutation identiﬁed in an Italian family with autosomal dominant non-syndromic hearing loss. (A) Multiple align-
ment of pre-miR-96 sequences (annotated in miRBase) from different vertebrate species obtained using the CLUSTALW software. The nt position +57 within
the human pre-miR-96 is indicated by an arrow. Mature miR-96 and miR-96∗ sequences are boxed, and their seed regions are underlined. hsa, Homo sapiens;
ppa, Pan paniscus; ptr, Pan troglodytes; ggo, Gorilla gorilla; mml, Macaca mulatta; mne, Macaca nemestrina; sla, Saguinus labiatus; mdo, Monodelphis domes-
tica; bta, Bos taurus; mmu, Mus musculus; rno, Rattus norvegicus; oan, Ornithorhynchus anatinus; fru, Fugu rubipres; tni, Tetraodon nigroviridis; dre, Danio
rerio.( B) Pedigree of the Italian NSHL family carrying the miR-96(+57T.C) mutation. Black symbols indicate affected subjects. The numbers within the
symbols represent: age of onset of NSHL (black symbols) and present age (empty symbols). Presence or absence of the mutation is indicated below the gen-
etically analyzed subjects. (C) Electropherogram depicting the pre-miR-96 sequence surrounding the mutated nt. (D) Audiograms showing the progression of the
hearing impairment in the proband (III-2). The age at which each audiometric record was obtained is indicated. Each graph point represents the average hearing
loss for the right and left ears.
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the miR-96(+57T.C) sequences, were generated and used to
transiently transfect HeLa cells. Total RNA was extracted
24 h after transfection, reverse transcribed and the expression
levels of mature miR-96, miR-96∗ as well as of pre-miR-96
were evaluated by real-time reverse-transcription polymerase
chain reaction (RT–PCR), with speciﬁc custom-designed
assays (Fig. 2B). Standard curves were generated to verify
thattheRT–PCRassayshadcomparableampliﬁcationefﬁcien-
cies (see Materials and Methods and Supplementary Material,
Fig. S2). In all experiments, miR-183 was used as internal
control to normalize for transfection efﬁciency. Interestingly,
expressionlevelsofbothmiR-96andmiR-96∗ weresigniﬁcant-
ly reduced in the mutant (+57T.C) compared with the wild-
type (85% reduction, P ¼ 0.0006 for miR-96 and 77% reduc-
tion,P ¼ 0.019,formiR-96∗,respectively),whereastheprecur-
sor levels were unaffected by the mutation (Fig. 2C). Similar
experimentswereperformedusingathirdexpressionvectorcar-
rying one of the known miR-96 mutations (+13G.A), previ-
ously shown, by Northern blot experiments, to decrease the
level of miR-96 (14). In this case, the mutant showed a signiﬁ-
cantreductioninmaturemiR-96(P , 0.0001)but,unexpected-
ly, miR-96∗ levels were unaffected (Fig. 2D), suggesting an at
least partially different pathogenic mechanism.
The same approach was used to verify whether presumably
non-pathogenic variants within MIR96 impact the normal
levels of the mature miRNA. Hence, we selected the two
known polymorphisms within MIR96 that are currently
Figure 2. Different functional consequences of the miR-96(+57T.C) and the known miR-96(+13G.A) mutations on miR-96/miR-96∗ biogenesis. (A) Pre-
dicted secondary structures of wild-type, mutant (+57T.C and +13G.A) and double-mutant (+23A.G+57T.C and +13G.A+66C.T) miR-96 precur-
sors obtained by using the mfold algorithm. The nt positions involved in the mutations are boxed. The double mutants were created to restore the pre-miR-96
secondary structure, in order to verify whether the defects in miRNA expression were dependent on correct folding of the hairpin precursor. Dicer cleavage sites
are indicated by arrows. (B) The positions of the 5′ primers used for real-time RT–PCR to quantify the levels of mature miRNA and pre-miRNA species. Primer
sequences are listed in Supplementary Material, Table S2. (C) The miR96(+57T.C) impairs the processing of pre-miR-96 to its mature forms, and is rescued
by a compensatory mutation (+23A.G) restoring the correct hairpin folding. (D) The known miR96(+13G.A) impairs mature miR-96, but not miR-96∗
levels, independently from the correct folding of the miR-96 precursor. The effect of the analyzed mutants on pre-miR-96 processing was evaluated by quan-
titative real-time RT–PCR using the △△CT method. Variations in the expression levels of mature miRNAs and pre-miR-96 in the miR-96(+57T.C) and
miR-96(+23A.G+57T.C) (C), or the known miR-96(+13G.A) and miR-96(+13G.A+66C.T) (D) mutants were compared with the wild-type
samples (set as 1). Bars stand for mean+SEM (represented as percentage of variation) of six independent experiments, each performed in triplicate in different
days on different cell batches and with different plasmid preparations. The results were analyzed by unpaired t-test (∗P , 0.05; ∗∗P , 0.01; ∗∗∗P , 0.001).
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+36T.C). Both are located within the loop region of the
miR-96 precursor, and were detected in the heterozygous
state in healthy controls during our genetic screening (Supple-
mentary Material, Fig. S3 and Table S1). No signiﬁcant alter-
ation of miR-96, miR-96∗ and pre-miR-96 levels was
measured by real-time RT–PCR, although the rs73159662
mutant tends to produce slightly elevated levels of both
mature miRNA species (Supplementary Material, Fig. S3).
The miR-96(157T>C) mutation is rescued by
reconstituting the precursor secondary structure
The miR-96(+57T.C) mutation causes a reduction in both
mature miRNAs but does not alter the expression level of
the miRNA precursor, thus suggesting a defect in the Dicer-
mediated cleavage.
This may be due to the modiﬁcation of the normal
pre-miR-96 secondary structure close to the Dicer cleavage
site, as predicted by mfold (see above and Fig. 2A). If this
is true, a second mutation that would reconstitute the pairing
of the +57 nt and hence the physiologic secondary structure
of the miR-96 precursor (Fig. 2A) should restore miR-96
and miR-96∗ levels. To verify this hypothesis, we transfected
HeLa cells with the double-mutant vector psiUX-miR-96(+23
A.G+57T.C), and evaluated the expression levels of
miR-96, miR-96∗ and pre-miR-96. Both miR-96 and
miR-96∗ levels were signiﬁcantly increased in the double
mutant compared with the +57T.C mutant (P ¼ 0.0003
and P ¼ 0.02, respectively) restoring mature miRNA expres-
sion at levels not signiﬁcantly different from the wild-type
(Fig. 2C). These results conﬁrm that reduced miR-96/
miR-96∗ levels, caused by the miR-96(+57T.C) mutation,
are a consequence of the altered precursor secondary structure.
As comparison, we next veriﬁed if also the effect of the
known miR-96(+13G.A) mutation could be rescued by
restoring the correct folding of the miR-96 precursor. In prin-
ciple, as this mutation does not impair the precursor expres-
sion and affects only one of the mature miRNA species
(Fig. 2D), it should not directly interfere with either the
Microprocessor-mediated or the Dicer-mediated cleavage
steps. Indeed, transfection of a double-mutant vector carrying
a compensatory mutation, psiUX-miR-96(+13G.A+66C.
T), conﬁrmed this hypothesis: miR-96 levels were still mark-
edly reduced in the double mutant compared with the wild-
type (P , 0.0001), and not signiﬁcantly different from the
+13G.A mutant, whereas the miR-96∗ and pre-miRNA
levels remained unaffected (Fig. 2D). These results indicate
that the known +13G.A mutation reduces mature miR-96
levels in a way that is independent from the correct folding
of the hairpin precursor, pointing again to different pathogenic
mechanisms for the +13G.A and the +57T.C mutations.
Impact of the 157T>C mutation on miRNA target
regulation
We next evaluated the effect of the miR-96(+57T.C) muta-
tion on the regulation of both miR-96 and miR-96∗ mRNA
targets by luciferase reporter assays. First, we selected eight
candidate target genes that: (i) contained either a 7-nt
perfect match or multiple 6-nt binding sites for the miR-96∗
and/or for the miR-96 seed region; (ii) were predicted as po-
tential miR-96/miR-96∗ targets by several bioinformatics pro-
grams (i.e. PITA, RNAhybrid, miRANDA/mirSVR) (20–22);
(iii) were reported in the literature to be expressed in the ver-
tebrate inner ear/auditory system (see below—Materials and
Methods). Three of them (ACVR2B, CACNB4 and MYRIP)
were predicted as common miR-96/miR-96∗ targets, whereas
the other ﬁve (ALCAM, BBS4, IQGAP2, PLS3 and ROCK2)
were targets of the miR-96∗ only (Supplementary Material,
Fig. S4). To validate the candidate targets, we co-transfected
a vector expressing either the wild-type or the mutant
pre-miR-96 hairpin into HeLa cells, together with a construct
containing the luciferase reporter cDNA coupled to the 3′UTR
of each target gene (psiCHECK2-3′UTR). This reporter
system showed that three (MYRIP, ACVR2B, CACNB4) out
of eight luciferase-3′UTR constructs were controlled by
human miR-96/miR-96∗ and that the miR-96(+57T.C)
mutation led, in all cases, to a signiﬁcantly reduced silencing
( 50%) of luciferase expression compared with the wild-type
pre-miR-96 (Fig. 3A and Supplementary Material, Fig. S5). In
particular, the MYRIP 3′UTR, which contains an already vali-
dated miR-96 target site (14) as well as a predicted miR-96∗
site, showed the most signiﬁcant regulation. To discriminate
between the relative effect of miR-96 and miR-96∗ on
MYRIP 3′UTR regulation, we created two mutant 3′UTR con-
structs in which the miR-96 or the miR-96∗ binding sites were
selectively disrupted. While the construct lacking the
miR-96∗-binding site was still signiﬁcantly responsive to
miR-96 repression (P , 0.01), the mutant deprived of
miR-96-binding site was not (Fig. 3A), indicating that
MYRIP 3′UTR is regulated uniquely by miR-96, and that the
predicted miR-96∗ binding site is not functional. Therefore,
the impaired regulation of MYRIP 3′UTR in the
miR-96(+57T.C) mutant is likely a consequence of the
reduced levels of miR-96, caused by the defect in
the hairpin processing. To conﬁrm this hypothesis, we
repeated the luciferase assays using the double miR-96(+23
A.G+57T.C) mutant, and observed that in this case the
downregulation of MYRIP 3′UTR was restored to a level
similar to that of the wild-type miR-96 (Fig. 3B). Hence, we
can conclude that a quantitative defect in miR-96 production
might be sufﬁcient to impair the regulation of at least some
of its downstream targets.
DISCUSSION
Here we report a novel mutation within the MIR96 gene that
causes autosomal dominant post-lingual progressive NSHL
in an Italian family. This is the third mutation described in
this gene in humans, and the ﬁrst in a different population
from that of the original report (14). The +57(T.C) variant
is also the ﬁrst mutation in the MIR96 gene that does not
affect the miR-96 seed region, neither its mature sequence.
Instead, our results indicate that this mutation alters the
correct maturation of the precursor miR-96, leading to a
decrease in the level of both its mature forms. In particular,
the +57(T.C) mutation is predicted to create an enlarge
bulge in the secondary structure of miR-96 hairpin, 5 nts 3′
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interfere with Dicer processing. Other studies have reported
that common SNPs within miRNA genes can lead to impaired
miRNA processing, and might be associated with increased
susceptibility to human diseases (23–25). Interestingly, one
SNP within the miR-146a, which confers an increased risk
to develop thyroid cancer, not only hindered the pre-miRNA
processing, but also affected the seed region of the companion
miR-146a∗, similarly to the miR-96(+57T.C) mutation. The
miR-146a∗ was expressed in both normal and tumor thyroid
tissues and the altered regulation of the miRNA∗ targets in het-
erozygotes compared with homozygotes was suggested as the
possible mechanism underlying tumor predisposition (26).
In the case of the miR-96(+57T.C) mutation, however, a
direct role of miR-96∗ in NSHL pathogenesis has still to be
proved. In fact, none of the putative miR-96∗ target sites
was validated by luciferase-based assays (Supplementary
Material, Fig. S5). Proﬁling of miR-96∗ expression in a
panel of human and mouse tissues evidenced that, although
expressed at very low levels, miR-96∗ shows some degree of
differential expression, suggesting that it might be regulated
in a tissue-speciﬁc manner (Supplementary Material,
Fig. S6). In the mouse Organ of Corti, the miR-96∗ could be
cloned, but not reliably quantitated by real-time RT–PCR.
More extensive and detailed experiments will be needed to
deﬁne the role, if any, of this miRNA∗ species in the inner
ear, as well as to evaluate the involvement of the mutant
miR-96∗ in NSHL.
Even though mutations within miR-96 are not a common
cause of deafness, as evidenced by this and previous works
(14,17), the description of novel causative variants might
help in elucidating the pathogenic mechanisms underlying
the DFNA50-associated phenotype. In particular, the function-
al analysis of the +57(T.C) mutation points to a contribution
of quantitative defects in miR-96 to hearing loss pathogenesis,
independently from additional qualitative defects (i.e. changes
in the actual mature miR-96 sequence). Indeed, tight regula-
tion of miR-96 levels within the vertebrate inner ear seems
to be crucial for the correct function and development of
hair cells, as demonstrated by knockdown experiments in zeb-
raﬁsh (11) and by the phenotypic differences between the het-
erozygous and the homozygous diminuendo mice (15,16).
Interestingly, also the three affected families (the two
Spanish and the here reported Italian one) show some degree
of phenotypic variation, suggesting that the pathogenic
mechanisms underlying each family’s phenotype might be at
least partially different. In particular, the family carrying the
+57(T.C) mutation is characterized by a late onset
(between 25 and 40 years) and a slow progression of the
hearing impairment. In addition, the presence of the mutation
in three young individuals of the last generation (Fig. 1B), who
currently have normal hearing at audiological analysis (Sup-
plementary Material, Fig. S1), suggests incomplete pene-
trance, although they might still develop the disease in the
future. The phenotypic differences with the previously
reported families might be partly explained by molecular ﬁnd-
ings: a quantitative defect of miR-96 expression may lead to a
delayed or reduced penetrance of the hearing impairment,
whereas mutations directly impairing miR-96 target recogni-
tion would probably result in an earlier defect of hearing. In
this respect, it should be recalled that the diminuendo
mouse, which carries a mutant miR-96 seed region, does not
have a major effect on miR-96 expression levels (15).
In conclusion, deciphering the different pathogenic mechan-
isms linking MIR96 mutations to progressive hearing loss will
be crucial for helping to develop new personalized therapeutic
approaches for people carrying these mutations.
MATERIALS AND METHODS
Patients selection
This study was approved by the local Ethical Committee of the
University of Milan and was performed according to the Dec-
laration of Helsinki and to the Italian legislation on sensible
data recording. Signed informed consent was obtained from
all participants and from parents of subjects younger than
Figure 3. The miR96(+57T.C) mutation impairs the regulation of MYRIP
by reducing mature miR-96 levels. (A) Downregulation of MYRIP 3′UTR is
only dependent on miR-96, and is impaired in the miR96(+57T.C)
mutant. The MYRIP 3′UTR reporter vectors (wild-type, or D96 and D96∗
mutants) were cotransfected with plasmids expressing either the wild-type
or the +57T.C mutant pre-miR-96. Mock samples were transfected with
the empty psiCHECK2 and psiUX vectors. (B) Restoration of correct
pre-miR-96 folding rescues the regulation of MYRIP 3′UTR. The wild-type
MYRIP 3′UTR reporter vector was cotransfected with the wild-type, the
+57T.C or the double-mutant (+23A.G+57T.C) pre-miR-96 expression
constructs. Relative luciferase activity is expressed as mean+SEM of six
independent experiments, each performed in triplicate in different days on
different cell batches and with different plasmid preparations. The luciferase
activity of the empty psiCHECK2 plasmid (A) or of the corresponding
psiCHECK2-3′UTR plasmid (B) is set as 1. The results were analyzed by
unpaired t-test (∗P , 0.05; ∗∗P , 0.01; ∗∗∗P , 0.001).
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cause of the hearing loss and physical examination did not
reveal any evidence of syndromic features.
A total of 882 genetically undiagnosed NSHL patients (fa-
milial 30%, and sporadic 70%) were recruited. All patients
underwent ear, nose and throat, and audiological examina-
tions. For adults and collaborative children, hearing levels
were determined by pure-tone audiometry, in accordance
with International Standard Organization (ISI 8253-1-3)
protocols. The hearing impairment diagnosis of small children
(,1 year) was obtained through the auditory brainstem
responses and the observation of their behaviors, whereas in
older children a behavioral audiometry was performed. In add-
ition, evoked otoacoustic emissions and tympanometry with
acoustic reﬂex thresholds were evaluated. Average thresholds
in the range of 21–40 dB were deﬁned as mild, 41–70 dB as
moderate, 71–95 dB as severe and .95 dB as profound
hearing loss. Finally, speciﬁc questions were asked to evaluate
olfactory, visual and vestibular functions.
All recruited patients did not carry mutations within gap-
junction proteins connexins 26 and 30 (GJB2, GJB6), and
the mitochondrial 12S rRNA (MTRNR1) genes.
A total of 120 individuals with no familiarity for
hearing loss and instrumentally veriﬁed normal auditory
function (mean age at withdrawal 32+9) were also collected
as controls. Additional 716 controls with a mean age .50
years and declared normal auditory function were also
recruited.
Mutational screening
Genomic DNA extraction from peripheral blood was per-
formed using a semi-automatic extractor (Fujiﬁlm Europe
GmBH, Du ¨sseldorf, Germany), whereas DNA from buccal
swabs from small children was puriﬁed according to the
QIAamp DNA Mini Kit extraction protocol (Qiagen, Hilden,
Germany). DNA samples were quantiﬁed on a Nanodrop
ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA), standardized for concentration,
arrayed into 96-well plates and stored at 2208C.
Although both previously reported miR-96 mutations were
found in families with autosomal dominant NSHL, we chose
to perform the mutational screening on all available genetically
undiagnosed NSHL patients, independently from the mode of
inheritance. Three sets of primer pairs were designed to PCR
amplify the genomic DNA fragments containing the precursor
sequences and ﬂanking regions of MIR183, MIR96 and
MIR182 (Supplementary Material, Table S1). PCR amplimers
were screened for mutations by HRM on a LigthCycler 480
using the HRM Master kit (Roche, Basel, Switzerland) and a
touch-down protocol (thermal proﬁles are available on
request). Amplicons were analyzed with the Gene Scanning
Software (Roche). Samples showing a melting proﬁle different
from the wild-type control were further analyzed by direct
sequencing, using the BigDye Terminator Cycle Sequencing
Ready Reaction Kit v1.1 (Applied Biosystems, Foster City,
CA, USA) and an ABI-3130XL sequencer, as previously
described(27).TheVariantReportersoftware wasusedformu-
tation detection (Applied Biosystems).
Computational methods
The mfold program (19) was used to evaluate the possible
impact of the +57T.C mutation on the secondary structure
of pre-miR-96.
We used the TargetRank program (28) to predict potential
miR-96, miR-96∗T (wild-type), and miR-96∗C (mutant)
targets and selected those genes that were either potential
targets of the wild-type miR-96∗ only, or targeted by both the
miR-96 and the wild-type miR-96∗, but not the mutant
miR96∗. Among these, we then selected for validation by luci-
ferase assays eight genes that: (i) contained either a 7-nt perfect
match or multiple 6-nt binding sites for the miR-96∗ and/or
miR-96 seed region; (ii) were predicted as potential miR-96/
miR-96∗T targets by additional bioinformatics programs (i.e.
PITA, RNAhybrid, miRANDA/mirSVR) (20–22); (iii) were
expressed in the inner ear/auditory system (15,29–34).
Expression vectors
To generate vectors for miRNA expression, genomic DNA
fragments including both the miR-183 and the miR-96 precur-
sors, and corresponding to either the miR-96 wild-type or the
miR-96(+57T.C) sequences, were ampliﬁed from genomic
DNA using modiﬁed primers (containing a KpnIo raXhoI
site at their 5′ends; Supplementary Material, Table S2),
inserted into the psiUX vector (kindly provided by prof.
I. Bozzoni, Universita ` di Roma La Sapienza) (35) and then
veriﬁed by sequencing. The psiUX-miR-96(+13G.A)
vector, carrying one of the known miR-96 mutations (14),
the double mutants, psiUX-miR-96(+23A.G+57T.C)
and psiUX-miR-96(+13G.A+66C.T) and the vectors car-
rying the two known MIR96 polymorphisms (rs73159662,
+42C.T; and rs41274239, +36T.C) were obtained by site-
directed mutagenesis using the QuikChange kit (Stratagene,
La Jolla, CA, USA), following the manufacturer’s instructions.
The entire 3′UTRs of putative target genes were ampliﬁed
from genomic DNA and directionally cloned into a psi-
CHECK2 vector (Promega, Madison, WI, USA), downstream
of the renilla luciferase gene. Constructs carrying mutant ver-
sions of miRNA binding sites (D96 and D96∗ binding sites)
were obtained by site-directed mutagenesis.
Ex-vivo analysis of miRNA expression and biogenesis
HeLa cells were cultured in Dulbecco’s modiﬁed Eagle
medium containing 2 mML -glutamine, 10% fetal bovine
serum and antibiotics (100 U/ml penicillin and 100 mg/ml
streptomycin; Euroclone, Wetherby, UK) and grown at 378C
in a humidiﬁed atmosphere of 5% CO2 and 95% air, according
to the standard procedures.
In each transfection experiment, an equal number of cells
(250 000) were transiently transfected in six-well plates with
the Fugene HD reagent (Promega) and 4 mg of plasmid
DNA, following the manufacturer’s instructions. Twenty-four
hours after transfection, cells were washed twice with
phosphate-buffered saline and total RNA was extracted
using the EUROzol reagent (Euroclone), according to the
manufacturer’s instructions. RNA concentration was quanti-
ﬁed by Nanodrop ND-1000 spectrophotometer (NanoDrop
Human Molecular Genetics, 2012, Vol. 21, No. 3 583Technologies). The miRNA First Strand Synthesis kit (Agilent
Technologies, Palo Alto, CA, USA) was used to reverse tran-
scribe miRNAs, starting from 300 ng of total RNA, according
to the manufacturer’s instructions. An aliquot (1 ml) of a 1:5
dilution of the RT reaction was used as template in a standard
real-time RT–PCR ampliﬁcation, using the universal reverse
primer (Agilent Technologies) and miRNA-speciﬁc forward
primers (Supplementary Material, Table S2). Although in
principle the primers for the ampliﬁcation of mature miR-96
and miR-96∗ can also amplify the pre-miRNA, real-time
RT–PCR conditions were set up to favor the ampliﬁcation
of the mature forms and the analysis of melting curves con-
ﬁrmed the presence of a single ampliﬁcation product (data
not shown). The speciﬁc 5′ primer used to amplify mature
miR-96∗ was designed downstream of the +57 nt position,
so that the same primer could be used to amplify both the
wild-type and the +57T.C mutant. Conversely, standard
curves were generated to verify that the RT–PCR assays to
detect: (i) wild-type miR-96, miR-96(+13G.A) or
miR-96(+23A.G); (ii) wild-type miR-96∗ and miR-96∗(+66
T.C); (iii) wild-type pre-miR-96, pre-miR-96(+42C.T) and
pre-miR-96(+36T.C) had comparable ampliﬁcation efﬁcien-
cies (Supplementary Material, Fig. S2). In all cases, real-time
RT–PCR assays were performed in triplicate on a LightCycler
480 (Roche), using a touch-down thermal proﬁle (PCR condi-
tions are available on request). MiRNA expression levels were
quantiﬁed by the △△CT method (36) using the miR-183,
co-expressed by the same construct, as internal normalization
reference. An unpaired, one-tailed t-test was performed to test
for signiﬁcant differences between the mutants and the wild-
type samples.
MiRNA target validation by luciferase assays
Transient transfections were performed by using the Fugene
HD reagent (Roche) and 2 mg of psiCHECK2-3′UTR con-
structs together with 0.2 mg of the wild-type, the mutant
(+57T.C) or the double-mutant (+23A.G+57T.C)
psiUX-miR-96 vector. In this case, the psiUX constructs
used for miRNA expression contained only the miR-96 pre-
cursor, thus avoiding the confounding effect of cloning the
related miR-183. Cells co-transfected with the empty psi-
CHECK2 and psiUX vectors served as mocks. Forty-eight
hours post-transfection, renilla and ﬁreﬂy luciferase activities
were measured in cell lysates using the Dual-Luciferase
Assay System (Promega) on a Wallac Victor 1420 Reader
(Perkin Elmer Life Sciences, Waltham, MA, USA). The
results were analyzed by unpaired t-test.
MiRNA expression proﬁle
Expression levels of miR-96 and miR-96∗ in a panel of RNAs
from human (First Choice total RNA; Ambion, Austin, TX,
USA) and adult mouse tissues were evaluated by
semi-quantitative real-time RT–PCR, using speciﬁc assays
(Supplementary Material, Table S2). The organs of Corti
from wild-type P4 mice (background 129S5) were kindly pro-
vided by prof. Karen Steel (Wellcome Trust Sanger Institute,
Hinxton, UK). Total RNA extraction was performed as
reported (15), and ﬁrst-strand cDNA synthesis was carried
out as described above. All assays were performed in triplicate
on a LightCycler 480 (Roche), using a touch-down thermal
proﬁle (PCR conditions are available on request). MiRNAs ex-
pression levels were quantiﬁed by the △△CT method using
either the U6 RNA (human) or the snoRNA 142 (mouse) as
internal normalization reference.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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